Psychiatric Times
Vol 41, Issue 3
Vol 41, Issue 2
Vol 41, Issue 1
Vol 40, Issue 12
Vol 40, Issue 11
Vol 40, Issue 10
Vol 40, Issue 9
Vol 40, Issue 8
Vol 40, Issue 7
Vol 40, Issue 6
Vol 40, Issue 5
Vol 40, Issue 4
Vol 40, Issue 3
Vol 40, Issue 2
Vol 40, Issue 1
Vol 39, Issue 12
Vol 39, Issue 11
Vol 39, Issue 10
Vol 39, Issue 9
Volume 39, Issue 9 Psychedelics Supplement
Vol 39, Issue 8
Vol 39, Issue 7
Vol 39, Issue 6
Vol 39, Issue 5
Vol 39, Issue 4
Vol 39, Issue 3
Vol 39, Issue 2
Vol 39, Issue 1
Vol 38, Issue 12 Sleep Supplement
Vol 38, Issue 12
Advertisement
Advertisement
Trending on Psychiatric Times
1
Disaster Psychiatry: Lessons From 9/11 and COVID-19
2
New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial: The Power of Another COMP360 Dose
3
The Postmodern Worldview and Contemporary Psychiatry
4
New Phase 2 Clinical Trial Initiating in 2027: Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
5